Depression in bipolar disorder (BPD) is challenging to treat. Therefore, additional medication options are needed. In a recent study, the effect of the neurosteroid pregnenolone on depressive symptoms in BPD was examined.
Adults (n=80) with BPD, depressed mood state, were randomized to pregnenolone (titrated to 500 mg/day) or placebo, as add-on therapy, for 12 weeks. Outcome measures included the 17-item Hamilton Rating Scale for Depression (HRSD), Inventory of Depressive Symptomatology—Self-Report (IDS-SR), Hamilton Rating Scale for Anxiety (HRSA), and Young Mania Rating Scale (YMRS).
The results suggest that pregnenolone may improve depressive symptoms in patients with BPD and can be safely administered.
READ FULL ARTICLE From Nature